Hanshu Ding

This inventor holds 22 USPTO granted patents and 5 published patent applications and 9 EPO patents, primarily in Enzymatic Biotechnology. Top assignees: Novozymes, Inc., Novozymes A/s. Active years: 2007-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanshu Ding. Retrieved from https://idiyas.com/inventor/hanshu-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 5)

% Patents Active = 40.9

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 119(Granted Patents)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2007-2021

Loading Chart...

Areas of Expertise:

Cellobiohydrolase

Xylanase

Beta-Glucosidase

Endoglucanase

Polypeptides

Cellulosic Material

Polynucleotides

Cellulolytic Enhancing

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11053489 - Cellobiohydrolase variants and polynucleotides encoding same (2021-07-06),

2. 10738293 - Cellobiohydrolase variants and polynucleotides encoding same (2020-08-11),

3. 10519520 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2019-12-31),

4. 10006016 - Polypeptides having xylanase activity and polynucleotides thereof (2018-06-26),

5. 9657283 - Polypeptides having xylanase activity and polynucleotides thereof (2017-05-23),

6. 8999694 - Polypeptides having xylanase activity and polynucleotides thereof (2015-04-07),

7. 8581042 - Polypeptides having beta-glucosidase activity and polynucleotides encoding same (2013-11-12),

8. 8431362 - Polypeptides having xylanase activity and polynucleotides encoding same (2013-04-30),

9. 8377693 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2013-02-19),

10. 8299322 - Polypeptides having xylanase activity and polynucleotides encoding same (2012-10-30),

11. 8227667 - Polypeptides having cellobiohydrolase activity and polynucleotides encoding same (2012-07-24),

12. 8211665 - Polypeptides having xylanase activity and polynucleotides encoding same (2012-07-03),

13. 8207400 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2012-06-26),

14. 8148495 - Methods for enhancing the degradation or conversion of cellulosic material (2012-04-03),

15. 8124394 - Polypeptides having cellobiohydrolase II activity and polynuleotides encoding same (2012-02-28),

Title: Innovations of Hanshu Ding: A Pioneer in Cellobiohydrolase Research

Introduction

Hanshu Ding is a renowned inventor based in Davis, California, holding an impressive portfolio of 22 patents. His work primarily focuses on biotechnological innovations that contribute significantly to various fields, including bioenergy and pharmaceuticals.

Latest Patents

Among his latest contributions, Hanshu Ding has developed cellobiohydrolase variants and the polynucleotides encoding them. The invention encompasses not only the variants themselves but also nucleic acid constructs, vectors, and host cells that incorporate these polynucleotides. Furthermore, the methods for producing and utilizing these variants showcase the practical applications of his innovative research.

Career Highlights

Throughout his career, Hanshu has made significant strides in the biotechnology sector, particularly during his tenure at Novozymes, Inc. and Novozymes A/S. His expertise has not only advanced the field but also led to the development of cutting-edge bioproducts that leverage his patented technologies.

Collaborations

Hanshu Ding has collaborated with notable individuals such as Paul Vincent Harris and Alfredo Lopez de Leon. These partnerships have enriched his work and contributed to the success of his innovative projects, fostering an environment of shared knowledge and expertise in biotechnology.

Conclusion

Hanshu Ding continues to be a driving force in the realm of biotechnological innovations. With his substantial number of patents and ongoing research, he is poised to make even greater contributions in the future, advancing our understanding and application of cellobiohydrolase variants and their potential benefits in various industries.

Profile summary based on public USPTO records.